Clinical Trial Update: A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating LY900014 in combination with insulin degludec in participants with Type 1 Diabetes has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• LY900014
• insulin degludec (insulin degludec)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 1 Diabetes | Phase 2 | Status: COMPLETED | Results posted: 2022-06-03